Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Esmail Al-Ezzi"'
Autor:
Esmail Al-Ezzi, Abhenil Mittal, Zachary W. Veitch, Amer Zahralliyali, Nely Mercy Diaz Mejia, Osama Abdeljalil, Husam Alqaisi, Vikaash Kumar, Aaron R. Hansen, Nazanin Fallah-Rad, Srikala S. Sridhar
Publikováno v:
Journal of Kidney Cancer and VHL, Vol 11, Iss 1 (2024)
Immunotherapy (IO) with or without targeted therapy (TT) is the standard treatment for patients with metastatic clear cell renal cell carcinoma (RCC). The evidence supporting their use in metastatic nonclear cell renal cell carcinoma (nccRCC) subtype
Externí odkaz:
https://doaj.org/article/b7d3d94769e84d84a091c0eecef9f662
Autor:
Abhenil Mittal, Esmail Al-Ezzi, Xuan Li, Brian Moloney, Brooke Wilson, Pavlina Spiliopoulou, Srikala Sridhar, Nazanin Fallah-Rad, Peter Chung, Robert James Hamilton, Martin O’malley, Aaron R. Hansen
Publikováno v:
British Journal of Cancer. 128:1888-1896
Background Outcomes for patients with metastatic renal cell carcinoma (mRCC) and tumour thrombus remain poor. Recent data suggest limited role for cytoreductive nephrectomy (CN) and data on thrombus response to systemic therapy (ST) is scarce. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ee406358e445ee1d4972630ac5425cb
https://doi.org/10.1038/s41416-023-02166-5
https://doi.org/10.1038/s41416-023-02166-5
Autor:
Abdulazeez Salawu, Aaron R. Hansen, Anna Spreafico, Esmail Al-Ezzi, Sheila Webster, Philippe L. Bedard, Jeffrey Doi, Lisa Wang, Lillian L. Siu, Albiruni R. Abdul Razak
Publikováno v:
Targeted oncology. 17(3)
Epidermal growth factor receptor (EGFR)- and human epidermal growth factor receptor (HER)2-targeted therapies are approved for the treatment of breast, gastric/gastrointestinal junction (GEJ), and non-small cell lung cancer (NSCLC) with specific mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b31d1ad2d472cb3b76ceee214bd6a1
https://pubmed.ncbi.nlm.nih.gov/35635640
https://pubmed.ncbi.nlm.nih.gov/35635640
Autor:
Mary Mahler, Esmail Al-Ezzi, Noa Shani Shrem, Liying Zhang, Eric Winquist, Christina Canil, Michael Ong, Aaron R. Hansen, Urban Emmenegger
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:539.e17-539.e22
To assess the effectiveness of docetaxel rechallenge (DR) for metastatic castration-resistant prostate cancer (mCRPC) following chemohormonal therapy for metastatic castrate-sensitive prostate cancer (mCSPC). Additionally, we sought to define clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8b4164a3f9482eceb80d554a186bfa
https://doi.org/10.1016/j.urolonc.2022.09.010
https://doi.org/10.1016/j.urolonc.2022.09.010
Autor:
Eoghan Ruadh Malone, Esmail al-Ezzi, Abha A. Gupta, Pernille Pedersen, Dagmara Kolodziejczyk, Ragitha Ellencherry, Oulu Zhu, Albiruni Ryan Abdul Razak, Jeremy Howard Lewin
Publikováno v:
Journal of Clinical Oncology. 36:11562-11562
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a39271b45de744b8c6b48547b06f0087
https://doi.org/10.1200/jco.2018.36.15_suppl.11562
https://doi.org/10.1200/jco.2018.36.15_suppl.11562